,Set,NGenes,Direction,PValue,FDR
1,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,1.76347274883624e-06,0.00144957459954339
2,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Up,2.96921711145474e-05,0.012203482328079
3,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.000151697601363191,0.0415651427735144
4,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.000220023394152521,0.0452148074983431
5,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.00376393093629614,0.618790245927086
6,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.00541349919627231,0.643061332703082
7,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.00547619139771481,0.643061332703082
8,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,19,Up,0.00927312677156256,0.656261770682992
9,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Up,0.00940029801872591,0.656261770682992
10,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Down,0.00950948263760916,0.656261770682992
11,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.0100744109527507,0.656261770682992
12,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.0117100343577968,0.656261770682992
13,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Up,0.0119067785293223,0.656261770682992
14,WP_VITAMIN_B12_DISORDERS,9,Up,0.012128263070302,0.656261770682992
15,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,71,Up,0.0129290161687086,0.656261770682992
16,WP_FERROPTOSIS,49,Up,0.0129599237711792,0.656261770682992
17,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,28,Up,0.0136547649807037,0.656261770682992
18,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.0145946959771288,0.656261770682992
19,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Up,0.0164580001494683,0.656261770682992
20,WP_SILDENAFIL_TREATMENT,12,Down,0.0173643566328952,0.656261770682992
21,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.0181945045726167,0.656261770682992
22,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0195964627109673,0.656261770682992
23,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.0202576024930087,0.656261770682992
24,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,6,Down,0.0211434468493631,0.656261770682992
25,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0213927041749388,0.656261770682992
26,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.0217255491174337,0.656261770682992
27,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,31,Up,0.0226646301638451,0.656261770682992
28,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0235633265540168,0.656261770682992
29,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.0238342973778286,0.656261770682992
30,WP_PROSTAGLANDIN_SIGNALING,20,Up,0.0239511595139778,0.656261770682992
31,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.0259883150992231,0.682076636700093
32,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,40,Up,0.0266503590971961,0.682076636700093
33,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.0289681765085604,0.682076636700093
34,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.0297171236169689,0.682076636700093
35,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.0302052627103506,0.682076636700093
36,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Up,0.0305312266101073,0.682076636700093
37,WP_PURINE_METABOLISM,10,Down,0.0314462240060676,0.682076636700093
38,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.0315315233510992,0.682076636700093
39,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.0343451520803186,0.723890128462099
40,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,3,Down,0.0353412856397619,0.726263419897108
41,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.0362805499190913,0.727380781304709
42,WP_SPINAL_CORD_INJURY,62,Up,0.0397394568408791,0.777757941028634
43,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Up,0.0423427518357105,0.785278688371605
44,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Up,0.0431437908759597,0.785278688371605
45,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.0435483461222829,0.785278688371605
46,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.0452945270028972,0.785278688371605
47,WP_BENZENE_METABOLISM,3,Up,0.0461178980989151,0.785278688371605
48,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,13,Up,0.0471817164304634,0.785278688371605
49,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.0473910457031884,0.785278688371605
50,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.0486877075426658,0.785278688371605
51,WP_AGERAGE_PATHWAY,53,Up,0.0497492299991592,0.785278688371605
52,WP_B_CELL_RECEPTOR_SIGNALING,82,Down,0.0533422668269267,0.785278688371605
53,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,34,Up,0.0538762988053695,0.785278688371605
54,WP_MELATONIN_METABOLISM_AND_EFFECTS,18,Up,0.054494063632391,0.785278688371605
55,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.0554105770013436,0.785278688371605
56,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.0570854211530398,0.785278688371605
57,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.057648035049231,0.785278688371605
58,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.0579357506128764,0.785278688371605
59,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0590497522088343,0.785278688371605
60,WP_MACROPHAGE_MARKERS,8,Down,0.0604887266067506,0.785278688371605
61,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.0636084183290692,0.785278688371605
62,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.0637594711917345,0.785278688371605
63,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.0638976346506538,0.785278688371605
64,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.0645488529346396,0.785278688371605
65,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.0646418552825498,0.785278688371605
66,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.0663504189838701,0.785278688371605
67,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,66,Up,0.0675853670995167,0.785278688371605
68,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.0678227634627125,0.785278688371605
69,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.0689680881525759,0.785278688371605
70,WP_NOTCH_SIGNALING_WP268,33,Up,0.0703412084138083,0.785278688371605
71,WP_DNA_REPLICATION,34,Up,0.0711713778023928,0.785278688371605
72,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.0716904571836409,0.785278688371605
73,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.0723257771210516,0.785278688371605
74,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.0735190003989083,0.785278688371605
75,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,14,Down,0.0737114343781521,0.785278688371605
76,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0756734559580406,0.785278688371605
77,WP_SPINA_BIFIDA,10,Down,0.0763212798883521,0.785278688371605
78,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Down,0.076668239304418,0.785278688371605
79,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Down,0.076668239304418,0.785278688371605
80,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.0774619898831732,0.785278688371605
81,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Down,0.0795860159575381,0.785278688371605
82,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.0800493439635067,0.785278688371605
83,WP_GPCRS_OTHER,11,Down,0.0810042085136135,0.785278688371605
84,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.0874137436207662,0.785278688371605
85,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Up,0.0886370529878376,0.785278688371605
86,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.0892084528355333,0.785278688371605
87,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.0893246413386793,0.785278688371605
88,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Up,0.0910254836392286,0.785278688371605
89,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0918308533613301,0.785278688371605
90,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.0937875870894806,0.785278688371605
91,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,11,Down,0.0941158873206526,0.785278688371605
92,WP_GPCRS_CLASS_B_SECRETINLIKE,3,Down,0.096639523988087,0.785278688371605
93,WP_RETINOL_METABOLISM,6,Up,0.0974680453656547,0.785278688371605
94,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.0977491046970766,0.785278688371605
95,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.0985627794368795,0.785278688371605
96,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,18,Up,0.0996920122779737,0.785278688371605
97,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.0999424241253407,0.785278688371605
98,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.100532630405456,0.785278688371605
99,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Up,0.101108767137454,0.785278688371605
100,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.101240999931228,0.785278688371605
101,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.101741008513101,0.785278688371605
102,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.102485389628794,0.785278688371605
103,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.103307775111897,0.785278688371605
104,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.104520705232926,0.785278688371605
105,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.104899760342484,0.785278688371605
106,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.106565757280936,0.785278688371605
107,WP_GPR40_PATHWAY,8,Down,0.108421230133698,0.785278688371605
108,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.109889025071161,0.785278688371605
109,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Up,0.110052421286745,0.785278688371605
110,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Up,0.110756817522794,0.785278688371605
111,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Down,0.113795422807453,0.785278688371605
112,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.115860329096501,0.785278688371605
113,WP_WNT_SIGNALING_WP363,35,Up,0.116104952494741,0.785278688371605
114,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,14,Down,0.116515896902898,0.785278688371605
115,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.117050766201397,0.785278688371605
116,WP_NUCLEAR_RECEPTORS,20,Down,0.117767766289905,0.785278688371605
117,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.117831398291057,0.785278688371605
118,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.119731468770818,0.785278688371605
119,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.119772691164633,0.785278688371605
120,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.119867193231196,0.785278688371605
121,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Down,0.120818076125194,0.785278688371605
122,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,73,Up,0.121586810473033,0.785278688371605
123,WP_PURINERGIC_SIGNALING,14,Up,0.121820674514464,0.785278688371605
124,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.121876761872606,0.785278688371605
125,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.122361307390745,0.785278688371605
126,WP_G13_SIGNALING,29,Up,0.123476144308177,0.785278688371605
127,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.124428607274406,0.785278688371605
128,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Up,0.12444112017944,0.785278688371605
129,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.124576651199374,0.785278688371605
130,WP_CELL_CYCLE,91,Up,0.1250547427161,0.785278688371605
131,WP_ENERGY_METABOLISM,41,Down,0.125147820166278,0.785278688371605
132,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.126745457182978,0.789278528821271
133,WP_LIPID_PARTICLES_COMPOSITION,4,Down,0.132342423110251,0.81793587817012
134,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.13960751276999,0.842762251697828
135,WP_NRF2_PATHWAY,68,Up,0.139785352315494,0.842762251697828
136,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Up,0.139917314633552,0.842762251697828
137,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,3,Down,0.141269628388788,0.842762251697828
138,WP_WNT_SIGNALING_WP428,56,Up,0.141860153437568,0.842762251697828
139,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.143373630972934,0.842762251697828
140,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.144584429234235,0.842762251697828
141,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Up,0.146929065217171,0.842762251697828
142,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.147428710727492,0.842762251697828
143,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.147852563954274,0.842762251697828
144,WP_VITAMIN_B12_METABOLISM,23,Up,0.1483869776759,0.842762251697828
145,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.15016083038414,0.842762251697828
146,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Up,0.15016564449855,0.842762251697828
147,WP_KIT_RECEPTOR_SIGNALING,49,Down,0.150712957420414,0.842762251697828
148,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.152125875607385,0.844915336143718
149,WP_MEASLES_VIRUS_INFECTION,99,Up,0.153824426741336,0.848615293834751
150,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.157054597358014,0.860659193521915
151,WP_IRON_METABOLISM_DISORDERS,10,Up,0.159439083589718,0.867939911991708
152,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.162955057616011,0.881243798423429
153,WP_DOPAMINE_METABOLISM,7,Up,0.164497384224975,0.883770260345946
154,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Down,0.168918832646183,0.901631691137417
155,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.170779779665599,0.905683734742726
156,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.172552839510709,0.909220731267965
157,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,132,Up,0.17405457570666,0.911292109750791
158,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.179006376729399,0.918586732191681
159,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.181904295417493,0.918586732191681
160,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.182576829014995,0.918586732191681
161,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Up,0.183682292410483,0.918586732191681
162,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.186079966566123,0.918586732191681
163,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,32,Up,0.186174972052709,0.918586732191681
164,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,45,Up,0.186615194400359,0.918586732191681
165,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.186996751851108,0.918586732191681
166,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.187094537706623,0.918586732191681
167,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,9,Up,0.187793481518852,0.918586732191681
168,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.188369091481527,0.918586732191681
169,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Down,0.188857856131866,0.918586732191681
170,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.190518074958239,0.918628409546449
171,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.191101530453093,0.918628409546449
172,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.194542397756713,0.920751506784937
173,WP_RAC1PAK1P38MMP2_PATHWAY,49,Up,0.199124783947261,0.920751506784937
174,WP_MESODERMAL_COMMITMENT_PATHWAY,72,Down,0.200541299063267,0.920751506784937
175,WP_HIPPOYAP_SIGNALING,16,Up,0.201829835164772,0.920751506784937
176,WP_ALZHEIMERS_DISEASE,181,Up,0.203357285092585,0.920751506784937
177,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,181,Up,0.203357285092585,0.920751506784937
178,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.203704860923207,0.920751506784937
179,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Down,0.205361844647528,0.920751506784937
180,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Up,0.207494242718145,0.920751506784937
181,WP_COPPER_HOMEOSTASIS,40,Up,0.207532043865787,0.920751506784937
182,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,52,Up,0.209000462968501,0.920751506784937
183,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.209594196437618,0.920751506784937
184,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.212210590489464,0.920751506784937
185,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.212355055899655,0.920751506784937
186,WP_ONECARBON_METABOLISM,22,Down,0.212736558840817,0.920751506784937
187,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.213956350966507,0.920751506784937
188,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,25,Up,0.214484637336748,0.920751506784937
189,WP_MRNA_PROCESSING,124,Down,0.215451537491243,0.920751506784937
190,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.215625655191954,0.920751506784937
191,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.217671424491687,0.920751506784937
192,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.218336413232994,0.920751506784937
193,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.218633469877841,0.920751506784937
194,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.220406887552083,0.920751506784937
195,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,8,Up,0.22069874388935,0.920751506784937
196,WP_KININKALLIKREIN_PATHWAY,2,Up,0.221449795263451,0.920751506784937
197,WP_NRF2ARE_REGULATION,20,Up,0.221602478776892,0.920751506784937
198,WP_MEVALONATE_PATHWAY,7,Up,0.222276133057129,0.920751506784937
199,WP_OREXIN_RECEPTOR_PATHWAY,113,Down,0.224073723032706,0.920751506784937
200,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.227957060082018,0.920751506784937
201,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.22925608013784,0.920751506784937
202,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.229528749655301,0.920751506784937
203,WP_HYPERTROPHY_MODEL,13,Up,0.230095925435414,0.920751506784937
204,WP_RETT_SYNDROME,29,Down,0.230812749863866,0.920751506784937
205,WP_CCL18_SIGNALING,19,Up,0.231290556315079,0.920751506784937
206,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Down,0.232292388492552,0.920751506784937
207,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.232989176209505,0.920751506784937
208,WP_TRYPTOPHAN_METABOLISM,17,Up,0.234662112424261,0.920751506784937
209,WP_SMALL_LIGAND_GPCRS,7,Up,0.235680919558009,0.920751506784937
210,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.236635110367589,0.920751506784937
211,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.237215663714865,0.920751506784937
212,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,17,Down,0.239167944147836,0.920751506784937
213,WP_NEURAL_CREST_DIFFERENTIATION,34,Up,0.24072572724623,0.920751506784937
214,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,50,Up,0.241498459157876,0.920751506784937
215,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,55,Down,0.242798936908941,0.920751506784937
216,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,60,Up,0.244576615228551,0.920751506784937
217,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.245682524079836,0.920751506784937
218,WP_NUCLEAR_RECEPTORS_METAPATHWAY,172,Up,0.246072191582735,0.920751506784937
219,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.247529818434534,0.920751506784937
220,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.249573599060098,0.920751506784937
221,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.250163939416502,0.920751506784937
222,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.250962764763569,0.920751506784937
223,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.251462156072,0.920751506784937
224,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.255150613512638,0.920751506784937
225,WP_MATRIX_METALLOPROTEINASES,7,Up,0.255298712406971,0.920751506784937
226,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,52,Down,0.255557739150088,0.920751506784937
227,WP_GASTRIN_SIGNALING,90,Up,0.2557884593788,0.920751506784937
228,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Up,0.261196625428066,0.920751506784937
229,WP_IL4_SIGNALING,50,Down,0.261297361282178,0.920751506784937
230,WP_PDGF_PATHWAY,36,Up,0.261345636370686,0.920751506784937
231,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.262207875989638,0.920751506784937
232,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.262693891256867,0.920751506784937
233,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.266624831862203,0.920751506784937
234,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Up,0.270121782638672,0.920751506784937
235,WP_JOUBERT_SYNDROME,70,Up,0.271740143569097,0.920751506784937
236,WP_CILIARY_LANDSCAPE,182,Up,0.274064457229573,0.920751506784937
237,WP_NEUROINFLAMMATION,10,Up,0.274256362230512,0.920751506784937
238,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.275674157722866,0.920751506784937
239,WP_IL19_SIGNALING,20,Up,0.276169647403798,0.920751506784937
240,WP_OSTEOBLAST_SIGNALING,3,Up,0.277022118144149,0.920751506784937
241,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.277143771083636,0.920751506784937
242,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.278772754515547,0.920751506784937
243,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.279963029871855,0.920751506784937
244,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.280318969619773,0.920751506784937
245,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.280482239165795,0.920751506784937
246,WP_ACUTE_MYELOID_LEUKEMIA,53,Down,0.281147103987477,0.920751506784937
247,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.281313503740427,0.920751506784937
248,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.283308182898351,0.920751506784937
249,WP_DRAVET_SYNDROME,11,Up,0.286306599314556,0.920751506784937
250,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.286895680488868,0.920751506784937
251,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.290862716304776,0.920751506784937
252,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.2954293189676,0.920751506784937
253,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.295573348892719,0.920751506784937
254,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.295629553618263,0.920751506784937
255,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.295678795742876,0.920751506784937
256,WP_AMINO_ACID_METABOLISM,57,Up,0.296962374127675,0.920751506784937
257,WP_PDGFRBETA_PATHWAY,26,Up,0.298316173691154,0.920751506784937
258,WP_BREAST_CANCER_PATHWAY,81,Up,0.29966588366192,0.920751506784937
259,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.301049576650496,0.920751506784937
260,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.304552222638141,0.920751506784937
261,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.305267217323267,0.920751506784937
262,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.305286051014633,0.920751506784937
263,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.30558190066741,0.920751506784937
264,WP_ANDROGEN_RECEPTOR_SIGNALING,76,Up,0.30564901067397,0.920751506784937
265,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Up,0.306370589059403,0.920751506784937
266,WP_LUNG_FIBROSIS,31,Up,0.306414040300207,0.920751506784937
267,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Up,0.30830069266873,0.920751506784937
268,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.309542717290826,0.920751506784937
269,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.310653280491019,0.920751506784937
270,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Up,0.315236262878501,0.920751506784937
271,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.320236503116758,0.920751506784937
272,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.321111046331468,0.920751506784937
273,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,16,Up,0.322922083732894,0.920751506784937
274,WP_CHOLESTEROL_METABOLISM,48,Up,0.324819811763957,0.920751506784937
275,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,32,Down,0.326164885299255,0.920751506784937
276,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.327055879574764,0.920751506784937
277,WP_SYNAPTIC_VESICLE_PATHWAY,21,Up,0.328565854779022,0.920751506784937
278,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,6,Up,0.331235666988143,0.920751506784937
279,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.331365129459003,0.920751506784937
280,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.332683911145437,0.920751506784937
281,WP_COMPLEMENT_ACTIVATION,12,Up,0.333149378697342,0.920751506784937
282,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Up,0.334051815099234,0.920751506784937
283,WP_AEROBIC_GLYCOLYSIS,9,Up,0.33407556588975,0.920751506784937
284,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Up,0.33407556588975,0.920751506784937
285,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.334959424978224,0.920751506784937
286,WP_AUTOPHAGY,27,Down,0.338520856896018,0.920751506784937
287,WP_VEGFAVEGFR2_SIGNALING,331,Up,0.339178308033755,0.920751506784937
288,WP_OPIOID_RECEPTOR_PATHWAYS,24,Up,0.340613988057933,0.920751506784937
289,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.343271986359622,0.920751506784937
290,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.344875961511372,0.920751506784937
291,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,40,Down,0.345183420437436,0.920751506784937
292,WP_NEPHROGENESIS,4,Down,0.345227133670804,0.920751506784937
293,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.346694224866913,0.920751506784937
294,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.346776826481768,0.920751506784937
295,WP_NRXN1_DELETION_SYNDROME,2,Down,0.34784021815114,0.920751506784937
296,WP_TP53_NETWORK,15,Down,0.349100270526754,0.920751506784937
297,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.349297247062898,0.920751506784937
298,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,87,Down,0.349533895880676,0.920751506784937
299,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,4,Down,0.3497761389131,0.920751506784937
300,WP_HISTONE_MODIFICATIONS,35,Down,0.350013794315822,0.920751506784937
301,WP_KLEEFSTRA_SYNDROME,25,Down,0.352257046208463,0.920751506784937
302,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.352480527443122,0.920751506784937
303,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,29,Down,0.352726057241167,0.920751506784937
304,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.354006865595952,0.920751506784937
305,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Up,0.354203116420398,0.920751506784937
306,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.354291736985262,0.920751506784937
307,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Up,0.354827039274219,0.920751506784937
308,WP_METABOLIC_EPILEPTIC_DISORDERS,55,Up,0.357713644276992,0.920751506784937
309,WP_PEPTIDE_GPCRS,11,Up,0.363019418230424,0.920751506784937
310,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.363557541044333,0.920751506784937
311,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.36436777124493,0.920751506784937
312,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Up,0.364803730922755,0.920751506784937
313,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Up,0.367253954352677,0.920751506784937
314,WP_BLADDER_CANCER,27,Down,0.368600334191461,0.920751506784937
315,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Up,0.36881511664894,0.920751506784937
316,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.368906069604094,0.920751506784937
317,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,9,Up,0.369489724300232,0.920751506784937
318,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.37014250202603,0.920751506784937
319,WP_G_PROTEIN_SIGNALING,59,Up,0.370558768419715,0.920751506784937
320,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.370954625020761,0.920751506784937
321,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.371295464652915,0.920751506784937
322,WP_HEPATITIS_B_INFECTION,114,Up,0.371976219838404,0.920751506784937
323,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.37209431227007,0.920751506784937
324,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Up,0.374032474621938,0.920751506784937
325,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.376645936873864,0.920751506784937
326,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,3,Up,0.378166272157548,0.920751506784937
327,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Up,0.38017813448832,0.920751506784937
328,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Down,0.380319629068506,0.920751506784937
329,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.380394966361907,0.920751506784937
330,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.380428048071984,0.920751506784937
331,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Up,0.382237861815866,0.920751506784937
332,WP_STEROID_BIOSYNTHESIS,2,Down,0.384085565552728,0.920751506784937
333,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,18,Up,0.38508398283299,0.920751506784937
334,WP_ENDOTHELIN_PATHWAYS,10,Up,0.385504372663475,0.920751506784937
335,WP_PRION_DISEASE_PATHWAY,27,Up,0.386464939038621,0.920751506784937
336,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.387743807662662,0.920751506784937
337,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.388123887498459,0.920751506784937
338,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.38814425927447,0.920751506784937
339,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.388606698979079,0.920751506784937
340,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.389404022764987,0.920751506784937
341,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.39144234195643,0.920751506784937
342,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.391826922792878,0.920751506784937
343,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.392679465134489,0.920751506784937
344,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.393423977987231,0.920751506784937
345,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Down,0.393670103056532,0.920751506784937
346,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.394228927952021,0.920751506784937
347,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.394913628602551,0.920751506784937
348,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.39492066133797,0.920751506784937
349,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Up,0.396382036817977,0.920751506784937
350,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.396458519865307,0.920751506784937
351,WP_MIRNA_BIOGENESIS,6,Up,0.397785495572432,0.920751506784937
352,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.398246453047647,0.920751506784937
353,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.398776235143144,0.920751506784937
354,WP_ESTROGEN_SIGNALING,21,Up,0.3988443774932,0.920751506784937
355,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.399855496222612,0.920751506784937
356,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.400939363919737,0.920751506784937
357,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.402135403064726,0.920751506784937
358,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.402813601316635,0.920751506784937
359,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.403109887071457,0.920751506784937
360,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.405137863519976,0.920751506784937
361,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Up,0.405535263694678,0.920751506784937
362,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.405761702111732,0.920751506784937
363,WP_TCA_CYCLE_IN_SENESCENCE,9,Up,0.40745524602472,0.920751506784937
364,WP_MONOAMINE_TRANSPORT,11,Up,0.408565070350705,0.920751506784937
365,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,12,Up,0.409625690272746,0.920751506784937
366,WP_PROTEASOME_DEGRADATION,57,Up,0.409969649006432,0.920751506784937
367,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.413265273130847,0.921237463407485
368,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.414364288581958,0.921237463407485
369,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.414882414926225,0.921237463407485
370,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.415525810711381,0.921237463407485
371,WP_ATM_SIGNALING,33,Down,0.416563323890512,0.921237463407485
372,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.421875866480155,0.921237463407485
373,WP_THERMOGENESIS,72,Down,0.422612035544745,0.921237463407485
374,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,12,Down,0.423935215622345,0.921237463407485
375,WP_FOCAL_ADHESION,115,Up,0.427067406594471,0.921237463407485
376,WP_ONCOSTATIN_M_SIGNALING,52,Down,0.427999775438815,0.921237463407485
377,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,62,Up,0.431609099161097,0.921237463407485
378,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.432462392774624,0.921237463407485
379,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,24,Down,0.432540884688676,0.921237463407485
380,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.433273817254237,0.921237463407485
381,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,87,Up,0.434287351381236,0.921237463407485
382,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,36,Down,0.437048851667199,0.921237463407485
383,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.437714256940232,0.921237463407485
384,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.439748667717029,0.921237463407485
385,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.439838211151523,0.921237463407485
386,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.440788843449419,0.921237463407485
387,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.441204161238958,0.921237463407485
388,WP_TARGET_OF_RAPAMYCIN_SIGNALING,31,Up,0.441321234670839,0.921237463407485
389,WP_IL26_SIGNALING,31,Up,0.446049056077335,0.921237463407485
390,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.450383310204274,0.921237463407485
391,WP_VITAMIN_D_RECEPTOR_PATHWAY,79,Up,0.450603255852388,0.921237463407485
392,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Up,0.451064787651827,0.921237463407485
393,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.451645979122285,0.921237463407485
394,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Up,0.45171553566356,0.921237463407485
395,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Up,0.451765516373623,0.921237463407485
396,WP_CREATINE_PATHWAY,2,Down,0.452086884219894,0.921237463407485
397,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.453646021185185,0.921237463407485
398,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.454386547710796,0.921237463407485
399,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.454386547710796,0.921237463407485
400,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,167,Down,0.456978967076502,0.921237463407485
401,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.457320424215285,0.921237463407485
402,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.457521181662037,0.921237463407485
403,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.457714492343043,0.921237463407485
404,WP_CANCER_PATHWAYS,291,Up,0.458051369970144,0.921237463407485
405,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.458215401433839,0.921237463407485
406,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.458604466886757,0.921237463407485
407,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.459079929024799,0.921237463407485
408,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.459218877452961,0.921237463407485
409,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.459857689333664,0.921237463407485
410,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.45994541507354,0.921237463407485
411,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.461149131451273,0.921237463407485
412,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.464681058402201,0.921237463407485
413,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.4671103693014,0.921237463407485
414,WP_VALPROIC_ACID_PATHWAY,9,Down,0.468955613648397,0.921237463407485
415,WP_ID_SIGNALING,11,Down,0.469873977612065,0.921237463407485
416,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.470723689225537,0.921237463407485
417,WP_TRANSLATION_FACTORS,49,Down,0.470911203137098,0.921237463407485
418,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.472956212749805,0.921237463407485
419,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Up,0.473878914994954,0.921237463407485
420,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.474652628214179,0.921237463407485
421,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.47486635476841,0.921237463407485
422,WP_FRAGILE_X_SYNDROME,83,Up,0.476381880539456,0.921237463407485
423,WP_NOTCH_SIGNALING_WP61,46,Up,0.477292222202534,0.921237463407485
424,WP_MELANOMA,53,Up,0.477634507065592,0.921237463407485
425,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Down,0.47805583170927,0.921237463407485
426,WP_CIRCADIAN_RHYTHM_GENES,114,Up,0.48056518626819,0.921237463407485
427,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.48204933023778,0.921237463407485
428,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.484150915458614,0.921237463407485
429,WP_TNFALPHA_SIGNALING,83,Up,0.4843240825456,0.921237463407485
430,WP_MTHFR_DEFICIENCY,18,Down,0.484542784989036,0.921237463407485
431,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.488867659962865,0.921237463407485
432,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.490377968306209,0.921237463407485
433,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.490980964613095,0.921237463407485
434,WP_HEME_BIOSYNTHESIS,8,Down,0.490980964613095,0.921237463407485
435,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.491889658972504,0.921237463407485
436,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.493047579343456,0.921237463407485
437,WP_CORI_CYCLE,11,Up,0.494632879597786,0.921237463407485
438,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.495259859084821,0.921237463407485
439,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.49650392714743,0.921237463407485
440,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.497479929701884,0.921237463407485
441,WP_PREIMPLANTATION_EMBRYO,21,Down,0.498183616853004,0.921237463407485
442,WP_IL5_SIGNALING,36,Up,0.499050663437189,0.921237463407485
443,WP_RAS_SIGNALING,113,Up,0.499614120562182,0.921237463407485
444,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Up,0.499842845575034,0.921237463407485
445,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.500071589846094,0.921237463407485
446,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.50015630512461,0.921237463407485
447,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Down,0.501208136410346,0.921237463407485
448,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Down,0.50208562482549,0.921237463407485
449,WP_FOXP3_IN_COVID19,9,Down,0.50675857204824,0.927740637469161
450,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.514239892717953,0.931656312679988
451,WP_NPHP1_DELETION_SYNDROME,10,Up,0.521961045820274,0.931656312679988
452,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.523186582271793,0.931656312679988
453,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.524182167684982,0.931656312679988
454,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.524826736375524,0.931656312679988
455,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.525044689204277,0.931656312679988
456,WP_BENZOAPYRENE_METABOLISM,5,Up,0.525270788530363,0.931656312679988
457,WP_CHOLESTASIS,8,Down,0.525467033099813,0.931656312679988
458,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.526087404466584,0.931656312679988
459,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.526898388936086,0.931656312679988
460,WP_METHYLATION_PATHWAYS,5,Up,0.527846882651368,0.931656312679988
461,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,3,Up,0.528821192873104,0.931656312679988
462,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,62,Up,0.529849546011734,0.931656312679988
463,WP_TROP2_REGULATORY_SIGNALING,41,Up,0.530032541267554,0.931656312679988
464,WP_ERBB_SIGNALING,65,Down,0.530198695165044,0.931656312679988
465,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.531325300799984,0.931656312679988
466,WP_IL9_SIGNALING,15,Down,0.53146263859129,0.931656312679988
467,WP_DNA_MISMATCH_REPAIR,21,Down,0.531627524942014,0.931656312679988
468,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.533286026884684,0.931656312679988
469,WP_KREBS_CYCLE_DISORDERS,11,Up,0.536654878061662,0.931656312679988
470,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.539292289319902,0.931656312679988
471,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,6,Down,0.540162293329579,0.931656312679988
472,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.541868611245067,0.931656312679988
473,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.542135418330575,0.931656312679988
474,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Up,0.543348938501677,0.931656312679988
475,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Up,0.544158507114162,0.931656312679988
476,WP_OSTEOPONTIN_SIGNALING,11,Down,0.544269008417185,0.931656312679988
477,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Down,0.544351407965606,0.931656312679988
478,WP_PLEURAL_MESOTHELIOMA,240,Up,0.544423149271363,0.931656312679988
479,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,47,Up,0.544478885184367,0.931656312679988
480,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,6,Up,0.545852783540941,0.931656312679988
481,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Up,0.547330836088817,0.931656312679988
482,WP_RANKLRANK_SIGNALING,47,Down,0.549145424572774,0.931656312679988
483,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.550500066252833,0.931656312679988
484,WP_ALSTROM_SYNDROME,27,Down,0.553243542570478,0.931656312679988
485,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.553374854495958,0.931656312679988
486,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.55463347240381,0.931656312679988
487,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Up,0.55557042744021,0.931656312679988
488,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.555926701778052,0.931656312679988
489,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Down,0.556091257912748,0.931656312679988
490,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.556254743400404,0.931656312679988
491,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Up,0.557562399688788,0.931656312679988
492,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.557633705399701,0.931656312679988
493,WP_GLUTATHIONE_METABOLISM,10,Up,0.561045990072953,0.933649290375458
494,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.562173757517493,0.933649290375458
495,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.563276898278102,0.933649290375458
496,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.563424583564611,0.933649290375458
497,WP_ARYLAMINE_METABOLISM,1,Up,0.564505714497083,0.933649290375458
498,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.566723669666624,0.935085654825609
499,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.568425842388417,0.935085654825609
500,WP_HIPPO_SIGNALING_REGULATION,42,Up,0.569697632766621,0.935085654825609
501,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.571861009850022,0.935085654825609
502,WP_IRINOTECAN_PATHWAY,5,Up,0.573039282615838,0.935085654825609
503,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,25,Up,0.573813623858121,0.935085654825609
504,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,16,Down,0.574415703342926,0.935085654825609
505,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Up,0.574612686164139,0.935085654825609
506,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.579889650273255,0.935085654825609
507,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.580079357956158,0.935085654825609
508,WP_TRANSSULFURATION_PATHWAY,8,Down,0.580952754087056,0.935085654825609
509,WP_IL17_SIGNALING,25,Down,0.583555445683517,0.935085654825609
510,WP_SLEEP_REGULATION,10,Down,0.584294201834417,0.935085654825609
511,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.584588499517559,0.935085654825609
512,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Down,0.58466596977613,0.935085654825609
513,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.586774386218147,0.935085654825609
514,WP_DNA_DAMAGE_RESPONSE,56,Up,0.587419744301361,0.935085654825609
515,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,35,Up,0.588112190903371,0.935085654825609
516,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.588367048386276,0.935085654825609
517,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.589683242062925,0.935085654825609
518,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.589744622302083,0.935085654825609
519,WP_TAR_SYNDROME,43,Up,0.59237022044025,0.935085654825609
520,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.596861332354488,0.935085654825609
521,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.59785518820683,0.935085654825609
522,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,20,Up,0.599225118771753,0.935085654825609
523,WP_BASE_EXCISION_REPAIR,29,Down,0.599579206498523,0.935085654825609
524,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.599849693978103,0.935085654825609
525,WP_LUNG_PATHOLOGY_OF_COVID19,14,Up,0.602388273544994,0.935085654825609
526,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.60251582542668,0.935085654825609
527,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Up,0.606012839929154,0.935085654825609
528,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.608863918851911,0.935085654825609
529,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.609058942030146,0.935085654825609
530,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.609058942030146,0.935085654825609
531,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.61010464467611,0.935085654825609
532,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.610289606515089,0.935085654825609
533,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.610354623357118,0.935085654825609
534,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,8,Up,0.611687412184858,0.935085654825609
535,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.612913281183823,0.935085654825609
536,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Up,0.612940733554726,0.935085654825609
537,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.614530938200862,0.935085654825609
538,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Down,0.615436031672751,0.935085654825609
539,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Up,0.616071230772893,0.935085654825609
540,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.617137325491127,0.935085654825609
541,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.617686297396051,0.935085654825609
542,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.617702096657847,0.935085654825609
543,WP_SPHINGOLIPID_PATHWAY,19,Up,0.617702567603778,0.935085654825609
544,WP_HUNGER_AND_SATIETY,2,Down,0.621504073639402,0.937581821443371
545,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.622050164117728,0.937581821443371
546,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.623309574040802,0.937581821443371
547,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.62391393714054,0.937581821443371
548,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Up,0.626948715715679,0.937683774354148
549,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.627220186059619,0.937683774354148
550,WP_IDO_METABOLIC_PATHWAY,6,Down,0.627538481113959,0.937683774354148
551,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.631382956087436,0.937683774354148
552,WP_EICOSANOID_SYNTHESIS,13,Down,0.632654534696111,0.937683774354148
553,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.635307728328059,0.937683774354148
554,WP_HEDGEHOG_SIGNALING_WP4249,24,Up,0.635540293054278,0.937683774354148
555,WP_MAPK_SIGNALING,158,Up,0.636076585516413,0.937683774354148
556,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.63627519115311,0.937683774354148
557,WP_NEOVASCULARIZATION_PROCESSES,21,Up,0.637442434994595,0.937683774354148
558,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.638141802753982,0.937683774354148
559,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Up,0.638640704828833,0.937683774354148
560,WP_RETINOBLASTOMA_GENE_IN_CANCER,64,Up,0.638811330460247,0.937683774354148
561,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,16,Up,0.647395957257061,0.94071068031394
562,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.647736586220635,0.94071068031394
563,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,38,Down,0.649363399277077,0.94071068031394
564,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,13,Down,0.651105263088212,0.94071068031394
565,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.652511400413003,0.94071068031394
566,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.653830468082833,0.94071068031394
567,WP_NAD_METABOLISM,12,Down,0.65403983889978,0.94071068031394
568,WP_CYTOSINE_METHYLATION,7,Down,0.656957884313338,0.94071068031394
569,WP_MONOAMINE_GPCRS,3,Up,0.657586659262847,0.94071068031394
570,WP_SERINE_METABOLISM,5,Down,0.658883948068725,0.94071068031394
571,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.659022050671184,0.94071068031394
572,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.660130032557025,0.94071068031394
573,WP_AXON_GUIDANCE,35,Up,0.660512065393871,0.94071068031394
574,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.661616878418208,0.94071068031394
575,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.661803112042635,0.94071068031394
576,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.662827562314265,0.94071068031394
577,WP_KALLMANN_SYNDROME,10,Up,0.662868517696476,0.94071068031394
578,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Up,0.663457936924878,0.94071068031394
579,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,10,Down,0.66545336360248,0.94071068031394
580,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.665705703054416,0.94071068031394
581,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.665832912193243,0.94071068031394
582,WP_OSTEOCLAST_SIGNALING,9,Up,0.668164334957144,0.94071068031394
583,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.668876225969724,0.94071068031394
584,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Up,0.67030942884821,0.94071068031394
585,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.671037769604999,0.94071068031394
586,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Down,0.671356636851512,0.94071068031394
587,WP_NUCLEOTIDE_GPCRS,6,Down,0.673740231247926,0.94071068031394
588,WP_TAMOXIFEN_METABOLISM,2,Up,0.675469989275756,0.94071068031394
589,WP_PPAR_SIGNALING,36,Up,0.675565932194101,0.94071068031394
590,WP_NEPHROTIC_SYNDROME,28,Up,0.677140436931702,0.94071068031394
591,WP_CHEMOKINE_SIGNALING,106,Down,0.677298608198696,0.94071068031394
592,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Up,0.678235181451719,0.94071068031394
593,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.680455004100873,0.94071068031394
594,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,31,Up,0.680692277833774,0.94071068031394
595,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.680928047185881,0.94071068031394
596,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,2,Down,0.685623805667651,0.944978271733516
597,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.687314118908951,0.944978271733516
598,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.687465944643117,0.944978271733516
599,WP_ZINC_HOMEOSTASIS,23,Down,0.691948870845435,0.949552540625956
600,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.694702138342725,0.950422671948948
601,WP_SMALL_CELL_LUNG_CANCER,67,Up,0.69579760228576,0.950422671948948
602,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.696051640527089,0.950422671948948
603,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,111,Up,0.701084110859447,0.951906141044114
604,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.70123831892497,0.951906141044114
605,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.701402287375074,0.951906141044114
606,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.701770220769748,0.951906141044114
607,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.703565906024122,0.952769645390162
608,WP_OXIDATION_BY_CYTOCHROME_P450,14,Up,0.708282817790738,0.95356980233602
609,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.708368321224894,0.95356980233602
610,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.708763188038363,0.95356980233602
611,WP_BARDETBIEDL_SYNDROME,64,Down,0.709708887922874,0.95356980233602
612,WP_IL1_SIGNALING,52,Up,0.710022966145789,0.95356980233602
613,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.711117139698273,0.95356980233602
614,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,19,Down,0.71393495635303,0.955789143521483
615,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,7,Up,0.715609632061055,0.956473361876728
616,WP_FOXA2_PATHWAY,9,Up,0.718060824678875,0.957892211112193
617,WP_IL3_SIGNALING,46,Down,0.720637461889802,0.957892211112193
618,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.720962320086197,0.957892211112193
619,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.721391472453052,0.957892211112193
620,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.722497774804817,0.957892211112193
621,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.724983106481911,0.958906231017258
622,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.729471124941121,0.958906231017258
623,WP_WNT_SIGNALING_AND_PLURIPOTENCY,55,Up,0.730325335289356,0.958906231017258
624,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.731409971686598,0.958906231017258
625,WP_PROLACTIN_SIGNALING,68,Down,0.731438082138235,0.958906231017258
626,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.732680432296795,0.958906231017258
627,WP_COMPLEMENT_SYSTEM,50,Up,0.733272036894767,0.958906231017258
628,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,43,Up,0.734211391038536,0.958906231017258
629,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,80,Up,0.734646200485995,0.958906231017258
630,WP_NONSMALL_CELL_LUNG_CANCER,57,Down,0.735283805745458,0.958906231017258
631,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.738084446867481,0.958906231017258
632,WP_5Q35_COPY_NUMBER_VARIATION,74,Down,0.739464648639208,0.958906231017258
633,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.74258387668162,0.958906231017258
634,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.746510297813202,0.958906231017258
635,WP_IL11_SIGNALING,40,Down,0.747404668157048,0.958906231017258
636,WP_EGFEGFR_SIGNALING,136,Up,0.747968516131444,0.958906231017258
637,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.749744884832798,0.958906231017258
638,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.749934410043162,0.958906231017258
639,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.750263108505715,0.958906231017258
640,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.751338976514663,0.958906231017258
641,WP_GASTRIC_CANCER_NETWORK_2,23,Down,0.752292032774083,0.958906231017258
642,WP_FOLATE_METABOLISM,36,Up,0.754353175120069,0.958906231017258
643,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,48,Down,0.754777255302022,0.958906231017258
644,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.75733206997788,0.958906231017258
645,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.757843229100035,0.958906231017258
646,WP_SEROTONIN_AND_ANXIETY,5,Down,0.758030251236784,0.958906231017258
647,WP_ENDOMETRIAL_CANCER,47,Down,0.758551788942328,0.958906231017258
648,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.760791199314699,0.958906231017258
649,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,79,Down,0.761085791044088,0.958906231017258
650,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.761508560628902,0.958906231017258
651,WP_IL18_SIGNALING,184,Up,0.763133617496789,0.958906231017258
652,WP_OVARIAN_INFERTILITY,21,Down,0.764309016213779,0.958906231017258
653,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,18,Down,0.765466211605421,0.958906231017258
654,WP_P38_MAPK_SIGNALING,30,Down,0.765984342517355,0.958906231017258
655,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,31,Down,0.766283700102923,0.958906231017258
656,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.768373018473188,0.958906231017258
657,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.768432429134135,0.958906231017258
658,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,87,Down,0.769061240874322,0.958906231017258
659,WP_GASTRIC_CANCER_NETWORK_1,15,Up,0.769584024612602,0.958906231017258
660,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.770096239843608,0.958906231017258
661,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,81,Down,0.771091263628233,0.958906231017258
662,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.775261092245917,0.962635374359734
663,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.778421156445932,0.964513227778771
664,WP_TGFB_SMAD_SIGNALING,7,Up,0.779120174264117,0.964513227778771
665,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.781108519759001,0.965501194078337
666,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.782267390822595,0.965501194078337
667,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.786124419101375,0.966448191158937
668,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.786791045724067,0.966448191158937
669,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.789326444991571,0.966448191158937
670,WP_TCELL_RECEPTOR_SIGNALING,71,Up,0.790814149798106,0.966448191158937
671,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.790926578417695,0.966448191158937
672,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.79097299073019,0.966448191158937
673,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.792288379953645,0.966448191158937
674,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.792440487641269,0.966448191158937
675,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.79612024314427,0.96751725184112
676,WP_ESTROGEN_METABOLISM_WP5276,8,Down,0.796776529552157,0.96751725184112
677,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,72,Up,0.798285965950725,0.96751725184112
678,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.800586632313606,0.96751725184112
679,WP_INTEGRATED_CANCER_PATHWAY,38,Down,0.800751684439512,0.96751725184112
680,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,13,Up,0.8024675182077,0.96751725184112
681,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.805562009330587,0.96751725184112
682,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.807969887666951,0.96751725184112
683,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.81124055824783,0.96751725184112
684,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.811308109342105,0.96751725184112
685,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.813039770850548,0.96751725184112
686,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.813103470289125,0.96751725184112
687,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Up,0.814585404316114,0.96751725184112
688,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.816116586873207,0.96751725184112
689,WP_UREA_CYCLE_AND_RELATED_DISEASES,2,Down,0.81691494661619,0.96751725184112
690,WP_IL7_SIGNALING,22,Up,0.818399588175062,0.96751725184112
691,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.819588613810547,0.96751725184112
692,WP_ENDODERM_DIFFERENTIATION,80,Down,0.82085052451777,0.96751725184112
693,WP_IL2_SIGNALING,36,Down,0.821499009703474,0.96751725184112
694,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.821861633354597,0.96751725184112
695,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.82327492713318,0.96751725184112
696,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.823461400407888,0.96751725184112
697,WP_CAMKK2_PATHWAY,29,Up,0.824011373567973,0.96751725184112
698,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.824697375149212,0.96751725184112
699,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.826220475026986,0.96751725184112
700,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.826803059320648,0.96751725184112
701,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Down,0.831976282608962,0.96751725184112
702,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.83261269653336,0.96751725184112
703,WP_ALLOGRAFT_REJECTION,50,Up,0.833030550124477,0.96751725184112
704,WP_OMEGA9_FATTY_ACID_SYNTHESIS,9,Down,0.833098060076199,0.96751725184112
705,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.833373206870386,0.96751725184112
706,WP_APOPTOSIS,70,Up,0.834328175127394,0.96751725184112
707,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.837388055438301,0.96751725184112
708,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.837930199259224,0.96751725184112
709,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Down,0.838117155148137,0.96751725184112
710,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.840100992872351,0.96751725184112
711,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,37,Down,0.840770533436171,0.96751725184112
712,WP_BDNFTRKB_SIGNALING,26,Up,0.841528288075559,0.96751725184112
713,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,83,Down,0.843089142741621,0.96751725184112
714,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,58,Up,0.84317106176914,0.96751725184112
715,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,10,Up,0.844972754324463,0.96751725184112
716,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,64,Up,0.846845628730152,0.96751725184112
717,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.847986492267673,0.96751725184112
718,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.847986492267673,0.96751725184112
719,WP_HEART_DEVELOPMENT,15,Down,0.848024519967575,0.96751725184112
720,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.848356299392057,0.96751725184112
721,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.849554690596719,0.96751725184112
722,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.849814423149987,0.96751725184112
723,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.851228780459039,0.967735605479252
724,WP_IL6_SIGNALING,39,Down,0.852574535382083,0.967735605479252
725,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.853690768205258,0.967735605479252
726,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.854715388780945,0.967735605479252
727,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Up,0.862316929113221,0.972052401820417
728,WP_MALE_INFERTILITY,66,Up,0.864722284421304,0.972052401820417
729,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,52,Up,0.866243785305008,0.972052401820417
730,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.867497087697324,0.972052401820417
731,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,59,Up,0.868544635742066,0.972052401820417
732,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.869145567425421,0.972052401820417
733,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.869156951850039,0.972052401820417
734,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,13,Up,0.871607091343541,0.972052401820417
735,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Up,0.8720061033383,0.972052401820417
736,WP_PPARALPHA_PATHWAY,14,Up,0.873211558388523,0.972052401820417
737,WP_NETRINUNC5B_SIGNALING,35,Down,0.873977413257017,0.972052401820417
738,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,27,Down,0.874220086185369,0.972052401820417
739,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.876243160786229,0.972052401820417
740,WP_PROTEOGLYCAN_BIOSYNTHESIS,14,Down,0.878534906802182,0.972052401820417
741,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.880621852688269,0.972052401820417
742,WP_PYRIMIDINE_METABOLISM,71,Down,0.881348242499463,0.972052401820417
743,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.881473380174264,0.972052401820417
744,WP_TCELL_ACTIVATION_SARSCOV2,61,Down,0.881664165498283,0.972052401820417
745,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.882097288491986,0.972052401820417
746,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.883153059771832,0.972052401820417
747,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.883582447971686,0.972052401820417
748,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.885866870573063,0.972052401820417
749,WP_ECTODERM_DIFFERENTIATION,74,Up,0.886527890225729,0.972052401820417
750,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,12,Up,0.886909125748556,0.972052401820417
751,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.888441706382678,0.972258864754083
752,WP_PARKINSONS_DISEASE_PATHWAY,26,Down,0.890865770288296,0.972258864754083
753,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.895081919468661,0.972258864754083
754,WP_BURN_WOUND_HEALING,57,Up,0.89581088463217,0.972258864754083
755,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Up,0.895972685528103,0.972258864754083
756,WP_INSULIN_SIGNALING,125,Down,0.896372676734642,0.972258864754083
757,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.896525888269859,0.972258864754083
758,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.896825473285173,0.972258864754083
759,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,59,Down,0.897742674389719,0.972258864754083
760,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Up,0.899121465715103,0.972470848444493
761,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,58,Up,0.902757445874278,0.975120394886539
762,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.904904417795215,0.975910930182137
763,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.905863795290719,0.975910930182137
764,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,29,Up,0.908377443456206,0.976246202317908
765,WP_GLUCURONIDATION,7,Up,0.908550297777616,0.976246202317908
766,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,3,Down,0.910414306903318,0.976972010802255
767,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Up,0.912616437053625,0.977930489520768
768,WP_CELLULAR_PROTEOSTASIS,6,Up,0.913686880720134,0.977930489520768
769,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.915360897751307,0.978448189793985
770,WP_GLIOBLASTOMA_SIGNALING,64,Down,0.917115033622291,0.978655589197219
771,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.922081823299296,0.978655589197219
772,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.92323042097052,0.978655589197219
773,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.923460035933787,0.978655589197219
774,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.924017953520597,0.978655589197219
775,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,14,Up,0.924548583714144,0.978655589197219
776,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.92552143900266,0.978655589197219
777,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,27,Up,0.927303823383599,0.978655589197219
778,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.92741509737033,0.978655589197219
779,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.928651289019258,0.978655589197219
780,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.928651289019258,0.978655589197219
781,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.932786153453585,0.981380900156183
782,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,9,Up,0.935370962190027,0.981380900156183
783,WP_GPCRS_CLASS_A_RHODOPSINLIKE,38,Up,0.935394690115222,0.981380900156183
784,WP_PI3KAKT_SIGNALING,171,Down,0.936967231714338,0.981380900156183
785,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.937206820708763,0.981380900156183
786,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,27,Up,0.938990830787575,0.981998044411434
787,WP_ATR_SIGNALING,10,Up,0.941950498426884,0.982697342551382
788,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.942050493832712,0.982697342551382
789,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.950219398746428,0.989708565845527
790,WP_MAPK_CASCADE,30,Down,0.951179765228669,0.989708565845527
791,WP_CILIOPATHIES,120,Up,0.952675024601765,0.990011213935083
792,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.956954012686718,0.992583275572311
793,WP_ASPIRIN_AND_MIRNAS,8,Up,0.957565130813677,0.992583275572311
794,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.964574691287647,0.992964266378658
795,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Up,0.965476002448245,0.992964266378658
796,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.966783695329653,0.992964266378658
797,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.967011191354746,0.992964266378658
798,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Down,0.967803188474123,0.992964266378658
799,WP_GLYOXYLATE_METABOLISM,5,Down,0.968038215174736,0.992964266378658
800,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.968213943751365,0.992964266378658
801,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.968659637223489,0.992964266378658
802,WP_ANGIOGENESIS,13,Down,0.969107851259598,0.992964266378658
803,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.97001253759375,0.992964266378658
804,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,11,Down,0.971568339731456,0.993319869725443
805,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.978992201368223,0.997152729268943
806,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.979581764528105,0.997152729268943
807,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.981847924230184,0.997152729268943
808,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.98248512536022,0.997152729268943
809,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.982804883144507,0.997152729268943
810,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.98331827442073,0.997152729268943
811,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.983996199318455,0.997152729268943
812,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.98502191747735,0.997152729268943
813,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.988459403014525,0.998907175197281
814,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.99051867362498,0.998907175197281
815,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.99164373784921,0.998907175197281
816,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.991815727100172,0.998907175197281
817,WP_ADIPOGENESIS,82,Down,0.992831097489268,0.998907175197281
818,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.996312742180164,0.99948614281744
819,WP_VITAMIN_D_METABOLISM,5,Down,0.997145032415717,0.99948614281744
820,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.997288351784391,0.99948614281744
821,WP_LEPTIN_SIGNALING,69,Up,0.998270222935667,0.99948614281744
822,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Up,0.999882849066208,0.999882849066208
